Imagine reducing the time to identify a drug that shows results in the clinic to five years: this proof-of-concept study shows how
HUB Organoids official news RSS · Indexed industry source record · Source published: Sat Mar 04 2023 01:56:32 GMT+0000 (Coordinated Universal Time) · Indexed here: Thu Oct 08 2026 07:03:32 GMT+0000 (Coordinated Universal Time)
Saved source excerpt
Patients with mutated KRAS (Kirsten rat sarcoma virus) gene account for around 30-50% of the population with colorectal cancer (CRC) and do not respond to cetuximab, a recognized choice of antibody therapy. A new proof-of-concept study led by the SuppresSTEM European consortium discovers a bispecific antibody that prevents the onset of metastasis and sedates the […] The post Imagine reducing the t
This is a cited excerpt from the source. Read the original link for the complete text. Automated indexing and topic classification do not constitute fact verification.